• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主包膜糖蛋白加工蛋白酶对于季节性流感病毒和高致病性禽流感病毒进入人类细胞而言不可或缺。

Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.

作者信息

Kido Hiroshi, Okumura Yuushi, Takahashi Etsuhisa, Pan Hai-Yan, Wang Siye, Chida Junji, Le Trong Quang, Yano Mihiro

机构信息

Division of Enzyme Chemistry, Institute for Enzyme Research, The University of Tokushima, Kuramoto-cho 3-18-15, Tokushima 770-8503, Japan.

出版信息

J Mol Genet Med. 2008 Nov 29;3(1):167-75.

PMID:19565019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2702071/
Abstract

Influenza A virus (IAV) is one of the most common infectious pathogens in humans and causes considerable morbidity and mortality. The recent spread of highly-pathogenic avian IAV H5N1 viruses has reinforced the importance of pandemic preparedness. In the pathogenesis of IAV infection, cellular proteases play critical roles in the process of viral entry into cells that subsequently leads to tissue damage in the infected organs. Since there are no processing protease for the viral membrane fusion glycoprotein hemagglutinin precursor (HA(0)) in IAV, entry of the virus into cells is determined primarily by the host cellular HA(0) processing proteases that proteolytically activate membrane fusion activity. HA(0) of seasonal human IAV has the consensus cleavage site motif Q(E)-T/X-R and is selectively processed by at least seven different trypsin-type processing proteases identified to-date in animal model experiments using mouse-adapted IAV or gene expression system in MDCK cells. As is the case for the highly pathogenic avian influenza (HPAI) A virus, endoproteolytic processing of the HA(0) occurs through ubiquitous cellular processing proteases, which selectively recognize the multi-basic consensus cleavage site motifs, such as R-X-K/R-R, and K-X-K/R-R. The cleavage enzymes for the R-X-K/R-R motif, but not K-X-K/R-R motif, have been reported to be furin and pro-protein convertase (PC)5/6 in the trans-Golgi network. Here we report new members of type II transmembrane serine proteases of the cell membrane, mosaic serine protease large form (MSPL) and its splice variant TMPRSS13, which recognize and cleave both R-X-K/R-R and K-X-K/R-R motifs without calcium. Furthermore, IAV infection significantly up-regulates a latent ectopic pancreatic trypsin, one of the potent HA processing proteases, and pro-matrix metalloprotease-9, in various organs. These proteases may synergistically damage the blood-brain barrier in the brain and basement membrane of blood vessels in various organs, resulting in severe edema and multiple organ failure. In this review, we discuss these proteases as new drug target molecules for IAV treatment acting by inhibition of IAV multiplication and prevention of multiple organ failure, other than anti-viral agents, viral neuraminidase inhibitors.

摘要

甲型流感病毒(IAV)是人类最常见的传染性病原体之一,可导致相当高的发病率和死亡率。高致病性禽流感IAV H5N1病毒最近的传播强化了大流行防范的重要性。在IAV感染的发病机制中,细胞蛋白酶在病毒进入细胞的过程中起着关键作用,随后导致受感染器官的组织损伤。由于IAV中没有用于病毒膜融合糖蛋白血凝素前体(HA(0))的加工蛋白酶,病毒进入细胞主要由宿主细胞的HA(0)加工蛋白酶决定,这些蛋白酶通过蛋白水解激活膜融合活性。季节性人类IAV的HA(0)具有共有切割位点基序Q(E)-T/X-R,并且在使用小鼠适应的IAV的动物模型实验或MDCK细胞中的基因表达系统中已鉴定出至少七种不同的胰蛋白酶型加工蛋白酶对其进行选择性加工。对于高致病性禽流感(HPAI)A病毒也是如此,HA(0)的内切蛋白水解加工通过普遍存在的细胞加工蛋白酶进行,这些蛋白酶选择性识别多碱性共有切割位点基序,如R-X-K/R-R和K-X-K/R-R。据报道,R-X-K/R-R基序的切割酶而非K-X-K/R-R基序的切割酶是反式高尔基体网络中的弗林蛋白酶和前蛋白转化酶(PC)5/6。在这里,我们报告了细胞膜II型跨膜丝氨酸蛋白酶的新成员,镶嵌丝氨酸蛋白酶大形式(MSPL)及其剪接变体TMPRSS13,它们在没有钙的情况下识别并切割R-X-K/R-R和K-X-K/R-R基序。此外,IAV感染显著上调潜伏的异位胰蛋白酶(一种有效的HA加工蛋白酶)和前基质金属蛋白酶-9在各种器官中的表达。这些蛋白酶可能协同破坏大脑中的血脑屏障和各种器官中血管的基底膜,导致严重水肿和多器官衰竭。在这篇综述中,我们讨论这些蛋白酶作为IAV治疗的新药物靶标分子如何通过抑制IAV增殖和预防多器官衰竭发挥作用,而非作为抗病毒药物、病毒神经氨酸酶抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088c/2702071/4cf5ec7b0558/jmgm-03-167-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088c/2702071/684ff0c8d249/jmgm-03-167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088c/2702071/e905750e95ae/jmgm-03-167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088c/2702071/9635a02368d6/jmgm-03-167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088c/2702071/4cf5ec7b0558/jmgm-03-167-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088c/2702071/684ff0c8d249/jmgm-03-167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088c/2702071/e905750e95ae/jmgm-03-167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088c/2702071/9635a02368d6/jmgm-03-167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088c/2702071/4cf5ec7b0558/jmgm-03-167-g004.jpg

相似文献

1
Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.宿主包膜糖蛋白加工蛋白酶对于季节性流感病毒和高致病性禽流感病毒进入人类细胞而言不可或缺。
J Mol Genet Med. 2008 Nov 29;3(1):167-75.
2
Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.新型跨膜丝氨酸蛋白酶 MSPL 和 TMPRSS13 可蛋白水解激活高致病性禽流感病毒血凝素的膜融合活性,并诱导其多轮复制。
J Virol. 2010 May;84(10):5089-96. doi: 10.1128/JVI.02605-09. Epub 2010 Mar 10.
3
Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure.宿主细胞蛋白酶在流感发病机制及流感诱导的多器官功能衰竭中的作用。
Biochim Biophys Acta. 2012 Jan;1824(1):186-94. doi: 10.1016/j.bbapap.2011.07.001. Epub 2011 Jul 23.
4
Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells.禽流感病毒的血凝素在人和鼠类的气道细胞中通过 TMPRSS2 被蛋白水解激活。
J Virol. 2021 Sep 27;95(20):e0090621. doi: 10.1128/JVI.00906-21. Epub 2021 Jul 28.
5
TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.TMPRSS2 是主要的甲型流感病毒激活蛋白酶在原代人呼吸道细胞和乙型流感病毒在人Ⅱ型肺泡细胞。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.00649-19. Print 2019 Nov 1.
6
Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options.宿主胰蛋白酶类丝氨酸蛋白酶和流感病毒-细胞因子-胰蛋白酶循环在流感病毒发病机制中的作用。基于发病机制的治疗选择。
Biochimie. 2019 Nov;166:203-213. doi: 10.1016/j.biochi.2019.09.006. Epub 2019 Sep 10.
7
Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics.流感病毒激活宿主蛋白酶:鉴定、定位和抑制剂作为潜在的治疗方法。
Eur J Cell Biol. 2015 Jul-Sep;94(7-9):375-83. doi: 10.1016/j.ejcb.2015.05.013. Epub 2015 Jun 1.
8
Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.人流感病毒进入细胞所必需的蛋白酶及其作为潜在治疗剂的抑制剂。
Curr Pharm Des. 2007;13(4):405-14. doi: 10.2174/138161207780162971.
9
TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.TMPRSS2 激活丙型流感病毒的血凝素-酯酶糖蛋白。
J Virol. 2021 Oct 13;95(21):e0129621. doi: 10.1128/JVI.01296-21. Epub 2021 Aug 18.
10
Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.转录组谱分析和蛋白酶抑制实验鉴定了在小鼠气道中激活 H3N2 流感 A 病毒和流感 B 病毒的蛋白酶。
J Biol Chem. 2020 Aug 14;295(33):11388-11407. doi: 10.1074/jbc.RA120.012635. Epub 2020 Apr 17.

引用本文的文献

1
Viral factors underlying the pandemic potential of influenza viruses.流感病毒大流行潜力的病毒因素。
Microbiol Mol Biol Rev. 2025 Jun 25;89(2):e0006624. doi: 10.1128/mmbr.00066-24. Epub 2025 May 9.
2
Human parainfluenza virus 3 field strains undergo extracellular fusion protein cleavage to activate entry.人类副流感病毒 3 野毒株通过细胞外融合蛋白裂解激活进入。
mBio. 2024 Nov 13;15(11):e0232724. doi: 10.1128/mbio.02327-24. Epub 2024 Oct 9.
3
Potential for transmission of naturally mutated H10N1 avian influenza virus to mammalian hosts and causing severe pulmonary disease.

本文引用的文献

1
Subtyping of avian influenza viruses H1 to H15 on the basis of hemagglutinin genes by PCR assay and molecular determination of pathogenic potential.基于血凝素基因通过聚合酶链反应检测对H1至H15亚型禽流感病毒进行分型及致病性潜力的分子测定。
J Clin Microbiol. 2008 Sep;46(9):3048-55. doi: 10.1128/JCM.02386-07. Epub 2008 Jul 2.
2
Substrate cleavage analysis of furin and related proprotein convertases. A comparative study.弗林蛋白酶及相关前体蛋白转化酶的底物切割分析。一项比较研究。
J Biol Chem. 2008 Jul 25;283(30):20897-906. doi: 10.1074/jbc.M803762200. Epub 2008 May 27.
3
MSPL/TMPRSS13.
自然突变的H10N1禽流感病毒向哺乳动物宿主传播并引发严重肺部疾病的可能性。
Front Microbiol. 2023 Sep 12;14:1256090. doi: 10.3389/fmicb.2023.1256090. eCollection 2023.
4
Sex and molecular differences in cardiovascular parameters at peak influenza disease in mice.在流感疾病高峰期,性别和分子差异对小鼠心血管参数的影响。
Physiol Genomics. 2023 Feb 1;55(2):79-89. doi: 10.1152/physiolgenomics.00146.2022. Epub 2023 Jan 16.
5
TMPRSS13 zymogen activation, surface localization, and shedding is regulated by proteolytic cleavage within the non-catalytic stem region.TMPRSS13 酶原的激活、表面定位和脱落受非催化茎区内部蛋白水解切割的调节。
Biol Chem. 2022 Jul 8;403(10):969-982. doi: 10.1515/hsz-2022-0129. Print 2022 Sep 27.
6
How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?包膜病毒如何利用分泌型蛋白前体转化酶来调节感染性和传播?
Viruses. 2021 Jun 25;13(7):1229. doi: 10.3390/v13071229.
7
The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.SARS-CoV-2 和其他人类冠状病毒的刺突蛋白针对人类气道的温度和蛋白酶进行了微调。
PLoS Pathog. 2021 Apr 22;17(4):e1009500. doi: 10.1371/journal.ppat.1009500. eCollection 2021 Apr.
8
Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza.抑制剂结合状态下的人 MSPL 晶体结构,该结构可激活高致病性禽流感。
Life Sci Alliance. 2021 Apr 5;4(6). doi: 10.26508/lsa.202000849. Print 2021 Jun.
9
Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的结构特征:我们所处的位置以及我们需要到达的位置。
Front Mol Biosci. 2020 Dec 17;7:605236. doi: 10.3389/fmolb.2020.605236. eCollection 2020.
10
Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status.靶向 SARS-CoV-2 的策略:小分子抑制剂-现状。
Front Immunol. 2020 Sep 18;11:552925. doi: 10.3389/fimmu.2020.552925. eCollection 2020.
MSPL/TMPRSS13。
Front Biosci. 2008 Jan 1;13:754-8. doi: 10.2741/2717.
4
Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens.将宿主细胞弗林蛋白酶原蛋白转化酶作为对抗细菌毒素和病毒病原体的治疗策略。
J Biol Chem. 2007 Jul 20;282(29):20847-53. doi: 10.1074/jbc.M703847200. Epub 2007 May 30.
5
Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.人流感病毒进入细胞所必需的蛋白酶及其作为潜在治疗剂的抑制剂。
Curr Pharm Des. 2007;13(4):405-14. doi: 10.2174/138161207780162971.
6
Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.人呼吸道上皮细胞中的丝氨酸蛋白酶TMPRSS2和HAT对流感病毒的蛋白水解激活作用。
J Virol. 2006 Oct;80(19):9896-8. doi: 10.1128/JVI.01118-06.
7
Impaired long-chain fatty acid metabolism in mitochondria causes brain vascular invasion by a non-neurotropic epidemic influenza A virus in the newborn/suckling period: implications for influenza-associated encephalopathy.
Mol Cell Biochem. 2007 May;299(1-2):85-92. doi: 10.1007/s11010-005-9046-x. Epub 2006 Aug 8.
8
Sendai virus infection up-regulates trypsin I and matrix metalloproteinase-9, triggering viral multiplication and matrix degradation in rat lungs and lung L2 cells.
Arch Virol. 2006 Dec;151(12):2529-37. doi: 10.1007/s00705-006-0807-y. Epub 2006 Jun 30.
9
Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.鉴定胰蛋白酶I作为大鼠脑中甲型流感病毒和仙台病毒包膜糖蛋白加工蛋白酶的候选物。
Biol Chem. 2006 Apr;387(4):467-75. doi: 10.1515/BC.2006.062.
10
Resistant influenza A viruses in children treated with oseltamivir: descriptive study.接受奥司他韦治疗的儿童中的甲型流感病毒耐药性:描述性研究
Lancet. 2004;364(9436):759-65. doi: 10.1016/S0140-6736(04)16934-1.